Zachary Benjamin Friend is named as a lobbyist on federal disclosure filings for 14 clients through Ferox Strategies. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Pharmacy, Trade (domestic/foreign) and Taxation/Internal Revenue Code.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| VIATRIS INC | FEROX STRATEGIES | Q3 2026 | Pharmacy |
| SURGENEX | FEROX STRATEGIES | Q3 2026 | Health Issues |
| STOKE THERAPEUTICS | FEROX STRATEGIES | Q3 2026 | Health Issues |
| RARE DISEASE COMPANY COALITION | FEROX STRATEGIES | Q3 2026 | Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues |
| NEURELIS, INC. | FEROX STRATEGIES | Q3 2026 | Medicare/Medicaid, Health Issues |
| NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA) | FEROX STRATEGIES | Q3 2026 | Trade (domestic/foreign), Health Issues |
| FRESENIUS KABI USA LLC | FEROX STRATEGIES | Q3 2026 | Trade (domestic/foreign), Pharmacy, Health Issues |
| THE ERISA INDUSTRY COMMITTEE (ERIC) | FEROX STRATEGIES | Q3 2026 | Insurance, Health Issues |
| ELI LILLY AND COMPANY | FEROX STRATEGIES | Q3 2026 | Pharmacy |
| AVIDITY BIOSCIENCES, INC. | FEROX STRATEGIES | Q3 2026 | Health Issues |
| ATRIUM THERAPEUTICS | FEROX STRATEGIES | Q3 2026 | Pharmacy, Health Issues |
| ALEXION PHARMACEUTICALS, INC. | FEROX STRATEGIES | Q3 2026 | Health Issues |
| ASSOCIATION FOR ACCESSIBLE MEDICINES | FEROX STRATEGIES | Q3 2026 | Trade (domestic/foreign), Pharmacy, Health Issues |
| AGE IN PLACE | FEROX STRATEGIES | Q2 2026 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 14 | 1 |
| 2025 | 6 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Zachary Benjamin Friend. See the Capitol Clarity rankings and method.